Research graph
References from Association of early IgM/IgA-enriched immunoglobulin therapy with long-term survival after septic shock: A propensity-score–matched multicentre cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
The third international consensus definitions for sepsis and septic shock (Sepsis-3)
10.1001/jama.2016.0287 · 2016 · External reference
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
10.1007/s00134-021-06506-y · 2021 · External reference
The pathophysiology of sepsis and precision-medicine-based immunotherapy
10.1038/s41590-023-01660-5 · 2024 · External reference
Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients
10.1016/j.intimp.2011.08.024 · 2011 · External reference
Beneficial role of endogenous immunoglobulin subclasses and isotypes in septic shock
10.1016/j.jcrc.2012.08.004 · 2012 · External reference
Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis
10.1111/joim.12265 · 2014 · External reference
The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis
10.1186/cc1523 · 2002 · External reference
Effects of IgM-enriched immunoglobulin therapy in septic-shock-induced multiple organ failure: pilot study
10.1007/s00540-012-1553-9 · 2013 · External reference
Relationship between the timing of administration of IgM- and IgA-enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome
10.1016/j.jcrc.2011.05.012 · 2012 · External reference
The clinical efficacy of intravenous IgM-enriched immunoglobulin in sepsis or septic shock: a meta-analysis with trial sequential analysis
10.1186/s13613-019-0501-3 · 2019 · External reference
IgM-enriched immunoglobulin as adjunctive therapy in adult sepsis and septic shock: a systematic review and meta-analysis of randomized controlled trials
2026 · External reference
Optimal caliper widths for propensity-score matching when estimating differences in means and proportions in observational studies
10.1002/pst.433 · 2011 · External reference
The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments
10.1002/sim.5984 · 2014 · External reference
Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
10.1186/1471-2288-13-152 · 2013 · External reference
Immortal time bias in observational studies of drug effects
10.1002/pds.1357 · 2007 · External reference
